Commission Implementing Decision (EU) 2023/1017 of 23 May 2023 amending Implementing Decision (EU) 2020/1729 as regards the monitoring of methicillin-resistant Staphylococcus aureus (MRSA) in fattening pigs (notified under document C(2023)3251) (Text with EEA relevance)

‘(2 National reference laboratories for AMR, or other laboratories designated by the competent authority in accordance with Article 37 of Regulation (EU) 2017/625, shall be responsible for carrying out: (a) the antimicrobial susceptibility testing of bacterial isolates, referred to in paragraph 1 of this Article, in accordance with the technical requirements set out in Part A, point 4, of the Annex; (b) the specific monitoring of ESBL-, AmpC- or CP-producing E. coli in accordance with the technical requirements set out in Part A, point 5, of the Annex; (c) the specific monitoring of MRSA in accordance with the technical requirements set out in Part A, point 5a, of the Annex; (d) the alternative method referred to in Part A, point 6, of the Annex.’

This Decision shall apply from 1 January 2025.

This Decision is addressed to the Member States.